Epstein Barr intsholongwane VCA IgG ELISA Kit

Inkcazelo emfutshane:

Isetyenziselwa ukufumanisa umgangatho we-IgG-class antibodies kwi-Epstein-barr virus capsid antigen kwi-serum yabantu okanye iplasma.Yenzelwe ukuba isetyenziswe kwiilabhoratri zeklinikhi zokuxilongwa kunye nokulawulwa kwezigulane ezinxulumene nosulelo lwe-Epstein-barr virus.

Usulelo lwe-EBV lunokubangela izifo ezifana ne-X-linked lymphoid hyperplasia syndrome (XLPS), i-post-transplant lymphoproliferative disorder, i-nasopharyngeal carcinoma, i-lymphoma ye-Burkitt kunye ne-infectious mononucleosis.I-anti-shell ye-antigen-IgM ekhangayo, i-anti-shell ye-antigen-IgG kunye ne-negative anti-EB i-antigen-IgG yenyukliya ibonisa usulelo oluphambili lwe-EBV;i-anti-shell antigen-IgG kunye ne-negative anti-EB i-antigen-IgG ibonisa usulelo lwamva nje lwe-EBV;i-anti-shell antigen-IgG kunye ne-positive anti-EB i-antigen-IgG ibonisa usulelo lwangaphambili lwe-EBV.

I-Nasopharyngeal Carcinoma yi-tumor enobungozi eyenzeka kwi-mucosa ye-nasopharynx kwaye ihambelana nokusuleleka kwe-EBV, i-genetics, indalo kunye nokutya.Iimpawu zeklinikhi ziquka ukulangazelela, ukuxinana kweempumlo, i-tinnitus, ukungeva, kunye nemvakalelo yokuvaleka endlebeni.Phakathi kwezifo ezininzi ezinxulumene ne-EBV, i-nasopharyngeal carcinoma ibonwa ngokubanzi ngenxa yeziganeko eziphezulu kunye nomngcipheko omkhulu.